Gross Margin

With real estate worth more than its stock and ambitious R&D plans, Cosmos Health claims it's undervalued. But is an unusual crypto strategy clouding the picture?

In an era of disruption, a REIT's acquisition of a Sprouts-anchored center in Arizona reveals a powerful trend: the surprising resilience of physical, necessity-based retail.

Despite a sales dip from a soft housing market, flooring supplier Q.E.P. Co. boasts a strong balance sheet and growing share among professional contractors.

Facing delisting, biotech firm Cuprina Holdings executes a reverse split and appeals to Nasdaq. Will the high-stakes gamble pay off for the company?

The maker of SUPERPRETZEL and ICEE maintains its shareholder payout, offering a competitive yield as it navigates market pressures and transformation.

OuterSignal's acquisition of Monocle unites deep customer intelligence with autonomous AI agents, heralding a new era of true 1:1 marketing personalization.

A new manufacturing deal positions ViCentra to serve thousands more diabetes patients in Europe and sets the stage for a future U.S. market challenge.

A top financial forum is urging a GST hike, corporate tax cuts, and a radical revamp of retirement savings in its bold 2026 federal budget proposal.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

Tribe Property Technologies reports its second straight quarter of positive adjusted EBITDA, signaling a shift toward sustainable growth and tech-led consolidation.

Investors don VR headsets to tour a utopian Dominican city, fueled by a booming market. But behind the digital polish of Larimar City lies a complex reality.

MNTN's CEO faces investors at two key June conferences. Amid record profits and a competitive market, the stakes are high for the CTV ad-tech firm.

With booming revenue and a new premium product on the horizon, Grindr's CFO is set to outline the company's ambitious future to investors this month.

The JOi Dollar Plus operator is upsizing its convertible debt offering, signaling strong investor confidence and a strategic pivot to retire senior debt.

After unprecedented growth, Clear Fork Bank names a new CEO known for community ties, signaling a strategy to blend legacy values with future expansion.

NewGenIVF, a firm with roots in fertility and facing financial headwinds, is investing in a $100M AI startup. Is it a visionary pivot or a risky gamble?

The iconic brand smashes revenue records and boosts dividends, fueled by new customers, Asian market growth, and a confident strategy for the future.

Dream Finders Homes escalates its takeover attempt of Beazer Homes with a public offer, citing a decade of underperformance and a failing strategy.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.